Effectiveness of Telemedicine in Inflammatory Bowel Disease in Russia
Author Information
Author(s): Akhmedzyanova Dina A., Shumskaya Yuliya F., Vasilev Yuriy A., Vladzymyrskyy Anton V., Omelyanskaya Olga V., Alymova Yulya A., Mnatsakanyan Marina G., Panferov Alexandr S., Taschyan Olga V., Kuprina Irina V., Yurazh Marta V., Eloev Artur S., Reshetnikov Roman V.
Primary Institution: Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
Hypothesis
The implementation of telemonitoring will lead to improvement in clinical, social, and organizational areas for patients with inflammatory bowel disease.
Conclusion
The trial will explore whether telemonitoring is effective in improving clinical, social, and organizational aspects in the management of patients with IBD in the Russian healthcare system.
Supporting Evidence
- Telemonitoring has been shown to be effective in improving outcomes for patients with IBD.
- Patients with IBD have a positive attitude towards the use of telemedicine technologies.
- A meta-analysis demonstrated that telemedicine significantly improved quality of life associated with IBD.
- IBD patients in the telemonitoring group had a lower risk of hospitalization compared to the standard-care group.
Takeaway
This study is trying to see if using telemedicine can help people with bowel diseases feel better and get better care without having to go to the doctor in person.
Methodology
The study is a randomized controlled trial with three stages: patient selection, follow-up care using telemonitoring or face-to-face appointments, and evaluation of follow-up efficacy.
Potential Biases
Potential differences in patient characteristics between the telemonitoring and control groups due to randomization method.
Limitations
The study is single-centered and may have uneven distribution of patients with ulcerative colitis and Crohn's disease.
Participant Demographics
Adults aged 18 and older with inflammatory bowel disease.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website